Echocardiography in Patients With Covid-19

Sponsor
University Hospital Tuebingen (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04412460
Collaborator
(none)
0
1
21.4
0

Study Details

Study Description

Brief Summary

Prospective observational study of patients treated due to Covid-19 disease. Observation and analysis of echocardiographic studies performed in the intensive care setting.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Echocardiography in Patients With Covid-19 Undergoing Intensive Care Therapy
    Actual Study Start Date :
    Mar 20, 2020
    Anticipated Primary Completion Date :
    Dec 31, 2021
    Anticipated Study Completion Date :
    Dec 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. ICU Mortality [up to 90 days]

    Secondary Outcome Measures

    1. ICU length-of stay [up to 90 days]

    2. ICU ventilator free days [up to 90 days]

    3. Hospital length-of-stay [up to 90 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age above 18 years

    • Covid-19 disease

    • invasive Ventilation

    Exclusion Criteria:
    • none

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital Tubingen Tubingen BW Germany 72076

    Sponsors and Collaborators

    • University Hospital Tuebingen

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital Tuebingen
    ClinicalTrials.gov Identifier:
    NCT04412460
    Other Study ID Numbers:
    • CovidEcho
    First Posted:
    Jun 2, 2020
    Last Update Posted:
    Sep 30, 2021
    Last Verified:
    May 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 30, 2021